Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeo Kuwata

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Microbiology Spectrum|June 13, 2023
Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic AssayMako Toyoda, Toong Seng Tan, Chihiro Motozono, et al.
Journal of Medicinal Chemistry|January 26, 2021
Hybrids of Small-Molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry InhibitorsTakuya Kobayakawa, Kohei Tsuji, Kiju Konno, et al.
Journal of Virology|January 14, 2021
A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus MacaquesSaori Matsuoka, Takeo Kuwata, Hiroshi Ishii, et al.
Journal of Virology|December 13, 2022
Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical IsolatesKaho Matsumoto, Takeo Kuwata, William D Tolbert, et al.
Journal of Virology|April 17, 2020
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected IndividualsYosuke Maeda, Taichiro Takemura, Takayuki Chikata, et al.
Cell Reports|July 8, 2021
Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19Yu Kaku, Takeo Kuwata, Hasan Md Zahid, et al.
Ebiomedicine|November 2, 2024
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection caseTakeo Kuwata, Yu Kaku, Shashwata Biswas, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Microbiology Spectrum|June 13, 2023
Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic AssayMako Toyoda, Toong Seng Tan, Chihiro Motozono, et al.
Journal of Medicinal Chemistry|January 26, 2021
Hybrids of Small-Molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry InhibitorsTakuya Kobayakawa, Kohei Tsuji, Kiju Konno, et al.
Journal of Virology|January 14, 2021
A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus MacaquesSaori Matsuoka, Takeo Kuwata, Hiroshi Ishii, et al.
Journal of Virology|December 13, 2022
Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical IsolatesKaho Matsumoto, Takeo Kuwata, William D Tolbert, et al.
Journal of Virology|April 17, 2020
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected IndividualsYosuke Maeda, Taichiro Takemura, Takayuki Chikata, et al.
Cell Reports|July 8, 2021
Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19Yu Kaku, Takeo Kuwata, Hasan Md Zahid, et al.
Ebiomedicine|November 2, 2024
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection caseTakeo Kuwata, Yu Kaku, Shashwata Biswas, et al.
Pageof 5